LifeScience BioChemicals
Kupando Raises €13 Million in Series A Funding Round
Kupando, a pioneering biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious disease...
September 27, 2022 | News
Most Read
- Hidden Pollution: Asia’s Rivers are Teeming with Pharmaceuticals
- Gibco Freedom ExpiCHO-S Cell Line Development Kit
- Samsung Biologics , AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy
- Honeywell Solstice Propellant Receives NMPA Registration for China New Cosmetic Raw Materials
- HKU microbiology researchers collaborating with vaccine manufacturers
- GenScript ProBio To Expands It's Manufacturing Capacity in China
- Scientists discover and name novel gene that governs left-right asymmetry within the human body
- Yokogawa developed the Single Cellome system SS2000 for subcellular sampling
Bio Jobs
- Step-by-step breakdown: How to write a strong resume
- Danaher Careers - Search Global Science and Technology Jobs
- Careers at MERCK Group
- Find your Job at Eppendorf
- Thermo Fisher Scientific - Singapore is hiring for Account Manager | Apply Now!
- Healthcare and Technology to remain key recruiting sectors for India's recovery in 2021
News
Editor Picks
